Select Medical Q4 revenue $1.58B (+1.4%), EPS $0.22; FY22 revenue $6.33B, EPS $1.23; declares $0.125 dividend

SELECT MEDICAL HOLDINGS CORP

2022-FY EPS reported $1.23 revenue$6,333,538,000

Q4 revenue $1,581.5M (+1.4% YoY); net income $37.7M (down 43%); EPS $0.22 vs $0.37.
FY22 revenue $6,333.5M (+2.1%); net income $198.0M (down 60%); EPS $1.23 vs $2.98.
Critical illness recovery hospital Q4 Adj EBITDA +80.5% to $44.3M; rehab hospital +42.5% to $56.0M.
Board declared $0.125/share cash dividend payable March 15, 2023 to holders of record March 3, 2023.
2023 revenue guidance $6.5B-$6.7B; no Adj EBITDA/EPS guidance due to labor uncertainties.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

SELECT MEDICAL HOLDINGS CORP reported fourth quarter ended December 31, 2022 results: revenue $1,581.5 million, net income $37.7 million, EPS $0.22.

Period: fourth quarter ended December 31, 2022
Revenue: $1,581.5 million
Net income: $37.7 million
EPS: $0.22
Result: reported results

Exact text from the filing

For the fourth quarter ended December 31, 2022, revenue increased 1.4% to $1,581.5 million, compared to $1,559.8 million for the same quarter, prior year. Income from operations increased 12.0% to $86.9 million for the fourth quarter ended December 31, 2022, compared to $77.5 million for the same quarter, prior year. For the fourth quarters ended December 31, 2022 and 2021, income from operations included $0.6 million and $8.0 million, respectively, of other operating income related to the recognition of payments received under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund. Net income was $37.7 million for the fourth quarter ended December 31, 2022, compared to $66.3 million for the same quarter, prior year. For the fourth quarter ended December 31, 2021, net income included a pre-tax gain on sale of businesses of $2.2 million. Adjusted EBITDA increased 7.6% to $148.9 m

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

SELECT MEDICAL HOLDINGS CORP reported year ended December 31, 2022 results: revenue $6,333.5 million, net income $198.0 million, EPS $1.23.

Period: year ended December 31, 2022
Revenue: $6,333.5 million
Net income: $198.0 million
EPS: $1.23
Result: reported results

Exact text from the filing

For the year ended December 31, 2022, revenue increased 2.1% to $6,333.5 million, compared to $6,204.5 million for the prior year. Income from operations was $403.3 million for the year ended December 31, 2022, compared to $713.8 million for the prior year. For the years ended December 31, 2022 and 2021, income from operations included $23.8 million and $123.8 million, respectively, of other operating income related to the recognition of payments received under the Provider Relief Fund. Net income was $198.0 million for the year ended December 31, 2022, compared to $499.9 million for the prior year. For the year ended December 31, 2021, net income included pre-tax gains on sales of businesses of $2.2 million. Adjusted EBITDA was $646.9 million for the year ended December 31, 2022, compared to $947.4 million for the prior year. Earnings per common share was $1.23 for the year ended December 31, 2022, compared to $2.98 for the prior year.

View on SEC.gov

Browse all earnings releases →

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-024791

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.